Spot the Difference—Development of a Syndrome Based Protein Microarray for Specific Serological Detection of Multiple Flavivirus Infections in Travelers

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Cleton, Natalie B ^a,b   Godeke, Gert Jan ^b   Reimerink, Johan ^b   Beersma, Mathias F ^a   Doorn, H Rogier van ^c,d   Franco, Leticia ^e   Goeijenbier, Marco ^a   Jimenez Clavero, Miguel A ^f   Johnson, Barbara W ^g   Niedrig, Matthias ^h   Papa, Anna ⁱ   Sambri, Vittorio ^j,k   Tami, Adriana ^l,m   Velasco Salas, Zoraida I ^l,m   Koopmans, Marion P G ^a,b   Reusken, Chantal B E M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

^g NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^h ROBERT KOCH INSTITUTE   (Germany)

ⁱ ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k Unit of Clinical Microbiology Greater Romagna Area Hub Laboratory   (Italy)

^l UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^m UNIVERSIDAD DE CARABOBO   (Venezuela)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTRUCTURAL PROTEIN 1; EPITOPE; NS1 PROTEIN, FLAVIVIRUS; VIRAL PROTEIN; VIRUS ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; POLYMERASE CHAIN REACTION; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROTYPE; VACCINATION; VIRUS NEUTRALIZATION; BLOOD; FEMALE; FLAVIVIRUS INFECTIONS; GENETICS; IMMUNOLOGY; MALE; MIDDLE AGED; PROCEDURES; TRAVEL;

ANTIBODIES, VIRAL; CROSS REACTIONS; EPITOPES; FEMALE; FLAVIVIRUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; TRAVEL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84928781032     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003580     Document Type: Article

References (40)

1. Wilson ME, Weld LH, Boggild A, Keystone JS, Kain KC, von Sonnenburg F, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clinical Infectious Diseases. 2007;44(12):1560–8. 17516399
2. Cleton N, Koopmans M, Reimerink J, Godeke GJ, Reusken C, Come fly with me: review of clinically important arboviruses for global travelers. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2012;55(3):191–203.
3. Guzmán MG, Kourı G, Dengue diagnosis, advances and challenges. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2004;8:69–80. 14732325
4. Hobson-Peters J, Approaches for the Development of Rapid Serological Assays for Surveillance and Diagnosis of Infections Caused by Zoonotic Flaviviruses of the Japanese Encephalitis Virus Serocomplex. Journal of Biomedicine and Biotechnology. 2012;Article ID 379738, 15 pages.
5. Heinz FX, Stiasny K, Flaviviruses and their antigenic structure. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2012;55(4):289–95.
6. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, West Nile virus. The Lancet Infectious Diseases. 2002;2(9):519–29. 12206968
7. Valassina M, Cusi MG, Valensin PE, A Mediterranean arbovirus: the Toscana virus. Journal of Neurovirology. 2003;9(6):577–83. 14602570
8. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB, Phylogeny of the genus Flavivirus. Journal of virology. 1998;72(1):73–83. 9420202
9. Allwinn R, Doerr HW, Emmerich P, Schmitz H, Preiser W, Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol. 2002;190(4):199–202. 12005333
10. Mansfield KL, Horton DL, Johnson N, Li L, Barrett ADT, Smith DJ, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(12):2821–9. doi: 10.1099/vir.0.031641-0 21900425
11. Koraka P, Zeller H, Niedrig M, Osterhaus AD, Groen J, Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes and Infection / Institut Pasteur. 2002;4(12):1209–15. 12467761
12. Papa A, Karabaxoglou D, Kansouzidou A, Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus. Journal of medical Virology. 2011;83(10):1861–5. doi: 10.1002/jmv.22180 21837806
13. Houghton-Triviño N, Montaña D, Castellanos J, Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Revista de salud publica. 2008;10(2):299–307. 19039426
14. Chavez JH, Silva JR, Amarilla AA, Moraes Figueiredo LT, Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Biologicals. 2010;38(6):613–8. doi: 10.1016/j.biologicals.2010.07.004 20817489
15. Beasley DWC, Holbrook MR, Travassos da Rosa A, Coffey L, Carrara AS, Phillippi-Falkenstein K, et al. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. Journal of Clinical Microbiology. 2004;42(6):2759. 15184463
16. Kuno G, Serodiagnosis of flaviviral infections and vaccinations in humans. Advances in Virus Research. 2003;61:3–65. 14714429
17. Muller DA, The flavivirus NS1 protein: Molecular and structural biology, immunology, role inpathogenesis and application as a diagnostic biomarker. Antiviral Research. 2013;98:192–208. doi: 10.1016/j.antiviral.2013.03.008 23523765
18. Lazaro-Olan L, Mellado-Sanchez G, Garcia-Cordero J, Escobar-Gutierrez A, Santos-Argumedo L, Gutierrez-Castaneda B, et al. Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens. Vec Borne Zoo Dis. 2008; 8:69–79.
19. Gromowski GD, Barrett ADT, Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology. 2007;366(2):349–60. 17719070
20. Gowri Sankar S, Balaji T, Venkatasubramani K, Thenmozhi V, Dhananjeyan KJ, Paramasivan R, et al. Dengue NS1 and prM antibodies increase the sensitivity of acute dengue diagnosis test and differentiate from Japanese encephalitis infection. Journal of Immunological Methods. 2014;407:116–9. doi: 10.1016/j.jim.2014.03.028 24732134
21. Hall RA, Kay BH, Burgess GW, Clancy P, Fanning ID, Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. J Gen Virol. 1990;71 (Pt 12):2923–30.
22. Falconar AK, Young PR, Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol. 1991;72 (Pt 4):961–5. 1849979
23. Falconar AK, Young PR, Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1. Journal of Virological Methods. 1990;30(3):323–32. 2150838
24. Konishi E, Shoda M, Ajiro N, Kondo T, Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses. Journal of Clinical Microbiology. 2004;42(11):5087–93. 15528700
25. Kitai Y, Shoda M, Kondo T, Konishi E, Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera. Clinical and Vaccine Immunology: CVI. 2007;14(8):1024–31. 17596430
26. Blitvich BJ, Marlenee NL, Hall RA, Calisher CH, Bowen RA, Roehrig JT, et al. Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to West Nile virus in multiple avian species. Journal of Clinical Microbiology. 2003;41(3):1041–7. 12624027
27. Koopmans M, de Bruin E, Godeke GJ, Friesema I, van Gageldonk R, Schipper M, et al. Profiling of humoral immune responses to influenza viruses by using protein microarray. Clinical Microbiology and Infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012;18(8):797–807.
28. Team RC. R: A language and environment for statistical computing. Version 3.1.0 ed. Vienna, Austria: R Foundation for Statistical Computing; 2014.
29. (NIBSC) NIfBSaC. WHO Reference Reagent: Anti-dengue virus types 1+2+3+4. NIBSC code: 02/186. Potters Bar, Hertfordshire: WHO International Laboratory for Biological Standards, UK Official Medicines Control Laboratory; 2013.
30. Ritz C, Streibig J, Bioassay Analysis using R. J Statist Software. 2005;12(5).
31. GraphPad Prism version 6.04 for Windows. San Diego California USA: GraphPad Software; 2013.
32. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerging Infectious Diseases. 2009;15(3):436–40. doi: 10.3201/eid1503.080923 19239758
33. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. The American Journal of Tropical Medicine and Hygiene. 1999;60(4):693–8. 10348250
34. Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD, Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clinical and Diagnostic Laboratory Immunology. 2000;7(6):867–71. 11063489
35. Buchy P, Peeling R, Laboratory Diagnosis and Diagnostic tests. In: WHO, editor. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. France: World Health Organization Press, Geneva, Swisterland; 2009. p. 91–109. 23762963
36. Kuno G, Gubler D, Oliver A, Use of ‘original antigenic sin’ theory to determine the serotypes of previous dengue infections. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87(1):103–5. 8465377
37. Monath TP, Yellow fever vaccine. Expert Review of Vaccines. 2005;4(4):553–74. 16117712
38. Jaafar FM, Attoui H, Bahar MW, Siebold C, Sutton G, Mertens PPC, et al. The structure and function of the outer coat protein VP9 of Banna virus. Structure. 2005;13(1):17–28. 15642258
39. Konishi E, Shoda M, Kondo T, Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine. 2006;24(4):516–24. 16129523
40. van Oirschot JT, Rziha HJ, Moonen PJ, Pol JM, van Zaane D, Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky’s disease virus by a competitive enzyme immunoassay. J Gen Virol. 1986;67 (Pt 6):1179–82.